Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelics industry news stories for the week of March 9th – 15th, 2020.
Without further ado, let’s get started.
10. The Burgeoning Psychedelics Sector Has Investors Tripping For an Opportunity to Ride the Shroom Boom
The emerging sector recently gained global media attention as two new Psychedelic Stocks went public. Champignon Brands (CSE: SHRM) (FRA: 496) was the first company to IPO, followed by MindMed (NEO: MMED) (OTC: MMEDF) (FRA: BGHM) a day later. While MMED garnered the majority of the media attention thanks to its backers Kevin O’Leary and former Canopy Growth (TSX: WEED) (NYSE: CGC) (FRA: 11L1) CEO Bruce Linton, it was SHRM that took home the honours as the week’s top-performing new Psychedelics IPO.
As Canadian cannabis companies monitor developments with the Coronavirus (COVID-19) pandemic, most major licensed producers (LPs) are still operating their cultivation facilities. Spokespeople from Canopy Growth (TSX: WEED) (NYSE: CGC) (FRA: 11L1), HEXO (TSX: HEXO) (NYSE: HEXO) (FRA: 74H), Aurora Cannabis (TSX: ACB) (NYSE: